These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 28094874)
1. Skin microbiome and acne vulgaris: Staphylococcus, a new actor in acne. Dreno B; Martin R; Moyal D; Henley JB; Khammari A; Seité S Exp Dermatol; 2017 Sep; 26(9):798-803. PubMed ID: 28094874 [TBL] [Abstract][Full Text] [Related]
2. Clinical assessment of topical erythromycin gel with and without zinc acetate for treating mild-to-moderate acne vulgaris. Sayyafan MS; Ramzi M; Salmanpour R J Dermatolog Treat; 2020 Nov; 31(7):730-733. PubMed ID: 30998422 [No Abstract] [Full Text] [Related]
3. Microorganisms inhabiting follicular contents of facial acne are not only Propionibacterium but also Malassezia spp. Akaza N; Akamatsu H; Numata S; Yamada S; Yagami A; Nakata S; Matsunaga K J Dermatol; 2016 Aug; 43(8):906-11. PubMed ID: 26705192 [TBL] [Abstract][Full Text] [Related]
5. Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics. Chien AL; Tsai J; Leung S; Mongodin EF; Nelson AM; Kang S; Garza LA JAMA Dermatol; 2019 Apr; 155(4):425-434. PubMed ID: 30758497 [TBL] [Abstract][Full Text] [Related]
6. Analysis of facial skin-resident microbiota in Japanese acne patients. Numata S; Akamatsu H; Akaza N; Yagami A; Nakata S; Matsunaga K Dermatology; 2014; 228(1):86-92. PubMed ID: 24356463 [TBL] [Abstract][Full Text] [Related]
7. The microbiome in preadolescent acne: Assessment and prospective analysis of the influence of benzoyl peroxide. Ahluwalia J; Borok J; Haddock ES; Ahluwalia RS; Schwartz EW; Hosseini D; Amini S; Eichenfield LF Pediatr Dermatol; 2019 Mar; 36(2):200-206. PubMed ID: 30656737 [TBL] [Abstract][Full Text] [Related]
8. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Eady EA; Bojar RA; Jones CE; Cove JH; Holland KT; Cunliffe WJ Br J Dermatol; 1996 Jan; 134(1):107-13. PubMed ID: 8745894 [TBL] [Abstract][Full Text] [Related]
9. Antibiotic-resistant acne: lessons from Europe. Ross JI; Snelling AM; Carnegie E; Coates P; Cunliffe WJ; Bettoli V; Tosti G; Katsambas A; Galvan Peréz Del Pulgar JI; Rollman O; Török L; Eady EA; Cove JH Br J Dermatol; 2003 Mar; 148(3):467-78. PubMed ID: 12653738 [TBL] [Abstract][Full Text] [Related]
10. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones. Resh W; Stoughton RB Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675 [TBL] [Abstract][Full Text] [Related]
11. The Skin Microbiome: A New Actor in Inflammatory Acne. Dréno B; Dagnelie MA; Khammari A; Corvec S Am J Clin Dermatol; 2020 Sep; 21(Suppl 1):18-24. PubMed ID: 32910436 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the forehead skin microbiome in the early phase of acne. Maître M; Gravier E; Simcic-Mori A; Géniès C; Mias C; Alvarez-Georges S; Noustens A; Bouyer K; Bessou-Touya S; Carballido F; Duplan H J Eur Acad Dermatol Venereol; 2024 Aug; 38 Suppl 7():3-11. PubMed ID: 39051132 [TBL] [Abstract][Full Text] [Related]
13. Distinct skin microbiome modulation following different topical acne treatments in mild acne vulgaris patients: A randomized, investigator-blinded exploratory study. Wongtada C; Prombutara P; Asawanonda P; Noppakun N; Kumtornrut C; Chatsuwan T Exp Dermatol; 2023 Jun; 32(6):906-914. PubMed ID: 36841971 [TBL] [Abstract][Full Text] [Related]
14. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. Mills O; Thornsberry C; Cardin CW; Smiles KA; Leyden JJ Acta Derm Venereol; 2002; 82(4):260-5. PubMed ID: 12361129 [TBL] [Abstract][Full Text] [Related]
15. Characterisation of Cutibacterium acnes phylotypes in acne and in vivo exploratory evaluation of Myrtacine Pécastaings S; Roques C; Nocera T; Peraud C; Mengeaud V; Khammari A; Dréno B J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():15-23. PubMed ID: 29894577 [TBL] [Abstract][Full Text] [Related]
16. Erythromycin-resistance of cutaneous bacterial flora in acne. Dreno B; Reynaud A; Moyse D; Habert H; Richet H Eur J Dermatol; 2001; 11(6):549-53. PubMed ID: 11701406 [TBL] [Abstract][Full Text] [Related]
17. The preadolescent acne microbiome: A prospective, randomized, pilot study investigating characterization and effects of acne therapy. Coughlin CC; Swink SM; Horwinski J; Sfyroera G; Bugayev J; Grice EA; Yan AC Pediatr Dermatol; 2017 Nov; 34(6):661-664. PubMed ID: 29024079 [TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea. Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337 [TBL] [Abstract][Full Text] [Related]
19. Noninflammatory comedones have greater diversity in microbiome and are more prone to biofilm formation than inflammatory lesions of acne vulgaris. Loss M; Thompson KG; Agostinho-Hunt A; James GA; Mongodin EF; Rosenthal I; Cheng N; Leung S; Chien AL; Kang S Int J Dermatol; 2021 May; 60(5):589-596. PubMed ID: 33615460 [TBL] [Abstract][Full Text] [Related]
20. Change in Cutibacterium acnes phylotype abundance and improvement of clinical parameters using a new dermocosmetic product containing Myrtus communis and Celastrol enriched plant cell culture extracts in patients with acne vulgaris. Mias C; Thouvenin MD; Gravier E; Dalmon S; Bouyer K; Alvarez S; Mengeaud V; Ribet V; Bessou-Touya S; Duplan H J Eur Acad Dermatol Venereol; 2023 Mar; 37 Suppl 2():20-25. PubMed ID: 36729402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]